DB15234InvestigationalProtein Based Therapies
Semorinemab is under investigation in clinical trial NCT03289143 (A Study to Evaluate the Efficacy and Safety of RO7105705 in Patients With Prodromal to Mild Alzheimer's Disease).
- Mechanism
- Curator reviewed
Pharmacologically active on Microtubule-associated protein tau
- Also known as
- MTAU9937A
- Code names
- RO7105705
Resolves to
Compound
Targets
What you can answer from here — as of June 15, 2026
Which drugs share a target with Semorinemab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account